https://parpreceptor.com/index.....php/prospective-eva
We revealed that passive transfer of a nAb provides security against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters, as uncovered by maintained weight and reduced lung viral titers in treated creatures. The analysis suggests a task for nAbs in prophylaxis, and potentially therapy, of COVID-19. The nAbs define safety epitopes to steer vaccine design.The quick spread of SARS-CoV-2 has
Like
Comment
Share
